echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Shihe Gene and AstraZeneca Strategic Cooperation: Co-build Guangzhou Biodiagnosis Innovation Center to Deploy Tumor Full Cycle Management

    Shihe Gene and AstraZeneca Strategic Cooperation: Co-build Guangzhou Biodiagnosis Innovation Center to Deploy Tumor Full Cycle Management

    • Last Update: 2021-07-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


















    Clinical testing service> 8 years


    Cooperate with Class III A/Tumor Specialty Hospitals> 500


    Accumulate the Chinese tumor NGS genome database> 420,000 cases


    Cumulative published SCI articles>260


    Cumulative Impact Factor (IF)>1700 points


    The self-developed "EGFR/ALK/ROS1/BRAF/KRAS/HER2 gene mutation detection kit (reversible terminal termination sequencing method)" (National Machinery Note 20183400408) was approved by the NMPA in September 2018, and comprehensively guides lung cancer targeted drugs , The sensitivity is as high as 1%
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.